AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metzer GV 1mg/500mg/0.2mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Tanzer Lifecare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Metzer GV 1mg/500mg/0.2mg Tablet ER

Diabex Trio 1mg/500mg/0.2mg Extended-Release tablets are antidiabetic agents, a combination medication for adult type 2 diabetes management. They help regulate blood glucose. Diabex Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical supervision can elevate blood sugar, risking complications such as kidney impairment, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn its symptoms (sweating, dizziness, headache, trembling) and management. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary foods, juice). Alcohol should be limited due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) may be recommended.

Uses of Metzer GV 1mg/500mg/0.2mg Tablet ER

Managing type 2 diabetes

Major Benefits of Metzer GV 1mg/500mg/0.2mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. The Metzer GV 1mg/500mg/0.2mg Extended-Release tablet should be taken on an empty stomach.

Common Side effects of Metzer GV 1mg/500mg/0.2mg Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Metzer GV 1mg/500mg/0.2mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Metzer GV 1mg/500mg/0.2mg Extended-Release tablet should be taken on an empty stomach.

How Metzer GV 1mg/500mg/0.2mg Tablet ER works:

Extended-release Metzer GV tablets (1mg/500mg/0.2mg) contain a triple-drug antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metzer GV 1mg/500mg/0.2mg Extended-Release Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Metzer GV 1mg/500mg/0.2mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Metzer GV 1mg/500mg/0.2mg tablet likely poses a risk during lactation. Available human data indicate potential drug transfer to breast milk, with the possibility of infant harm.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The extended-release Metzer GV 1mg/500mg/0.2mg tablet is likely unsafe for individuals with kidney impairment and its use should be avoided. Medical advice is recommended. Furthermore, its administration is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Metzer GV 1mg/500mg/0.2mg Extended-Release tablets cautiously, as dose modification may be necessary. Individuals with severe liver disease should avoid this medication. For those with mild to moderate liver disease, initiation at a lower dosage is usually advised. Physician consultation is recommended.

What if you forget to take Metzer GV 1mg/500mg/0.2mg Tablet ER :

Should you forget to take your Metzer GV 1mg/500mg/0.2mg Extended-Release tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Never take a double dose.

Facts to Know About Metzer GV 1mg/500mg/0.2mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metzer GV 1mg/500mg/0.2mg Tablet ER

Metzer GV 1mg/500mg/0.2mg Extended-Release tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Metzer GV 1mg/500mg/0.2mg ER tablets may cause common side effects including low blood sugar, nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infections.
Metzer GV 1mg/500mg/0.2mg Tablet ER is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Mixing Metzer GV 1mg/500mg/0.2mg ER tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Metzer GV 1mg/500mg/0.2mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metzer GV 1mg/500mg/0.2mg...
95
MRP 110
13% off